0.05 ml Semaglutide: Clearing Up a Common Measurement Confusion

The misconception: 0.05 ml as if it were a legitimate starting dose

The figure "0.05 ml" circulates widely on social media forums, and many people arrive at this page believing it describes the correct amount of semaglutide to inject at the beginning of treatment. That belief is wrong, and it is worth being direct about why.

The 0.05 ml figure typically comes from compounded semaglutide sold as a vial with a separate syringe, a product that has no MHRA marketing authorisation for weight management in the UK. To convert millilitres into milligrams, you would need to know the exact concentration of the solution, which varies between compounders. Two vials labelled "0.05 ml" from different sources could contain very different amounts of active drug. This is precisely the kind of variability that pharmaceutical licensing exists to prevent.

The NHS medicines information for semaglutide is clear about how the licensed medicine is presented: as a pre-filled injection pen, dosed in milligrams, at fixed strengths. There is no step in the licensed treatment pathway that asks a patient to measure out a volume with a syringe. If a source is asking you to do that, the product it's describing is not Wegovy. Our semaglutide overview covers how the medicine is properly classified and licensed in the UK.

How licensed Wegovy doses are actually structured

Wegovy's dose ladder is defined entirely in milligrams: treatment begins at 0.25 mg weekly, moves through 0.5 mg, 1.0 mg, and 1.7 mg, and reaches a maintenance dose of 2.4 mg. A higher 7.2 mg dose was approved by the MHRA in January 2026, with a dedicated single-dose pen confirmed in April 2026. At every stage, the pen delivers the right amount automatically, no measurement required from the patient.

This structure matters because titration exists for a reason. The body adjusts to semaglutide gradually; moving too fast through dose increases raises the chance of nausea, vomiting, and other gastrointestinal effects. A prescriber controls the pace. With a vial and syringe, that safeguard disappears entirely, because the dose is whatever volume the patient draws up, based on arithmetic that assumes the concentration is both accurate and consistent. Our Wegovy treatment guide explains the full dosing schedule and what to expect at each stage.

NICE's appraisal of semaglutide for weight management, published as TA875, assessed the licensed injectable formulation at 2.4 mg. Compounded versions were not part of that evaluation, and NICE recommendations do not extend to them.

What 0.05 semaglutide searches are often really looking for

People searching for "0.05 ml semaglutide" often have a genuine and reasonable question underneath the terminology: what is the right starting dose, and how little can I begin with to reduce side effects? That is a sensible concern. The answer, within licensed treatment, is that the prescriber manages this, and the starting dose is 0.25 mg weekly in the pen format. It is not something you calculate from a concentration and a syringe.

Some searches come from people who have already purchased compounded semaglutide and are trying to verify a dose instruction. If that is your situation, the safest step is to speak with a prescriber or pharmacist who can assess what you have and whether it is appropriate to continue. Common questions about taking other medicines alongside semaglutide are best resolved the same way: with a clinician, not a forum.

The cost context for licensed Wegovy in the UK is also worth understanding, because compounded semaglutide is sometimes framed as a cheaper alternative. A lower price on an unlicensed product is not a saving if the product carries unknown concentration, unknown purity, and no regulatory oversight. Compounded vials come in varying sizes, and if you have seen references to a 3 ml semaglutide vial or to a 5 ml semaglutide vial, those are formats associated with unlicensed compounded products rather than anything within the regulated UK treatment pathway. For context on what legitimately priced private treatment includes, that page is a useful reference.

How to access licensed semaglutide through a regulated UK pharmacy

If you want semaglutide for weight management in the UK, the legal route is a prescription issued by a qualified prescriber following a clinical assessment. That assessment considers your BMI, any weight-related health conditions, your current medicines, and your medical history. Adults with a BMI of 30 or above, or 27 or above with a qualifying condition such as high blood pressure or high cholesterol, may be eligible, though BMI alone does not determine the outcome.

At nume, every consultation is read by a GPhC-registered Independent Prescriber. A real clinician reviews your answers, not software. If you order on a weekday before noon (worth knowing if you're planning around a payday delivery or a bank holiday week) and your prescription is approved, your treatment is dispatched the same day and arrives by tracked DPD the next working day, in plain unbranded packaging. The consultation is free. So is delivery. Our clinical team is available for aftercare seven days a week.

You can verify any online pharmacy on the GPhC register before placing an order. It takes about thirty seconds, and it's the clearest way to confirm you're dealing with a regulated service. If you have further questions about how semaglutide treatment works or whether you might be suitable, our frequently asked questions cover the most common ones in plain terms.